Skip to content

Ampulla Of Vater Small Cell Neuroendocrine Carcinoma C1332250

Published: July 22, 2026Updated: August 20, 2026

A rare, aggressive neuroendocrine cancer of the Ampulla of Vater arising from hormone-producing cells. It tends to grow and spread quickly. Treatment may involve surgery, chemotherapy, and other targeted approaches.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Obstructive jaundice

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Weight loss

(constitutional)

Abdominal pain

(gastrointestinal)

Carcinoid syndrome (flushing and diarrhea)

(endocrine)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Platinum-Based Chemotherapy

First-line systemic chemotherapy using platinum agents combined with etoposide for small cell neuroendocrine carcinoma of the ampulla of Vater, targeting the aggressive neuroendocrine component.

medication
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Radical Surgical Resection

Aggressive surgical resection including pancreaticoduodenectomy with lymphadenectomy when the tumor is localized, as these tumors have high metastatic potential even when seemingly localized.

surgical

Additional treatment options

Topotecan Therapy

Second-line chemotherapy option using topotecan for patients with progressive disease following platinum-based regimens, particularly for refractory or relapsed small cell carcinoma.

medication

Endoscopic Biliary Decompression

Endoscopic placement of biliary stents or nasobiliary drains to relieve malignant biliary obstruction caused by the tumor, improving quality of life and liver function.

procedure

Nutritional Support

Specialized nutritional intervention including pancreatic enzyme supplementation and dietary modifications to maintain nutritional status during intensive chemotherapy treatment.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Ampulla Of Vater Small Cell Neuroendocrine Carcinoma C1332250?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Benson AB, Ajani JA, Engelstein BJ, et al. NCCN Clinical Practice Guidelines in Oncology: Neuroendocrine and Adrenal Tumors. J Natl Compr Canc Netw. 2023.

guideline2023
2

Zhang L, Wang LW, Chen Z, et al. Small Cell Neuroendocrine Carcinoma of the Ampulla of Vater: A Systematic Review. Pancreas. 2021.

review2021
3

Kim JH, Lee SH, Choi EK, et al. Neuroendocrine Tumors of the Ampulla of Vater: Clinicopathological Features and Prognostic Factors. Ann Surg Oncol. 2020.

review2020
4

Washington MK, Goldberg RM, Chang GJ, et al. Protocol for the Examination of Specimens from Patients with Carcinoma of the Ampulla of Vater. Arch Pathol Lab Med. 2019.

other2019

Medication Comparisons

Compare medications used to treat Ampulla Of Vater Small Cell Neuroendocrine Carcinoma C1332250. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy